Moreover, the combination of ALT and WNT/β-catenin inhibitor (KYA1197K) resulted in a synergistic effect on inhibiting the proliferation, migration and invasion of osteosarcoma cells [162]. The gene discussed is GPT; the disease is osteosarcoma.